Pyrotinib and Subcutaneous Preparation of Trastuzumab Combined With Capecitabine Neoadjuvant Therapy for HER2+ Study of Breast Cancer

NCT06483386 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

109

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Pyrotinib and Subcutaneous preparation of trastuzumab combined with capecitabine

Sponsor

Tianjin Medical University Cancer Institute and Hospital